{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:16:28Z","timestamp":1782252988752,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Senior Medical Talents Program of Chongqing for Young and Middle-aged","award":["2020-219"],"award-info":[{"award-number":["2020-219"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Erythropoietic protoporphyria is an inherited disorder characterized by mutations in the\n                      <jats:italic>FECH<\/jats:italic>\n                      gene, which encodes the enzyme ferrous chelatase. These mutations disrupt normal heme synthesis, leading to the accumulation of protoporphyrin in erythrocytes and other tissues. Clinical manifestations include cutaneous photosensitivity, characterized by burning and itching of the skin, and, less commonly, liver failure.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case description<\/jats:title>\n                    <jats:p>\n                      A teenager presented with abdominal pain, distention, and jaundice, along with a history of suspected photosensitivity. Lab tests revealed abnormal liver enzymes. Imaging showed liver cirrhosis. Liver biopsy confirmed bile accumulation and protoporphyrin deposits. Genetic testing identified a complex heterozygous mutation in the\n                      <jats:italic>FECH<\/jats:italic>\n                      gene, leading to a diagnosis of EPP.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The patient ultimately succumbed to complications arising from decompensated cirrhosis, specifically ruptured esophagogastric fundal varices and hepatorenal syndrome. We retrospectively reviewed 98 cases of EPP reported in English literature over the past decade (2014\u20132024). The overall mortality rate was 4.1% (4 patients).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Patients diagnosed with EPP may exhibit hepatic dysfunction as their primary clinical manifestation. In the evaluation of the etiology of liver dysfunction, EPP, a rare genetic disorder, should be considered. This case report describes a novel mutation in the\n                      <jats:italic>FECH<\/jats:italic>\n                      gene located at chr18-55226418 (c.763G\u2009&gt;\u2009T, exon 7), thereby contributing to the expanding spectrum of known\n                      <jats:italic>FECH<\/jats:italic>\n                      gene mutations.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-03860-8","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T08:53:35Z","timestamp":1751446415000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Erythropoietic protoporphyria linked to intricate double heterozygous mutations in theFECH gene: a case report and literature review"],"prefix":"10.1186","volume":"20","author":[{"given":"Hongli","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruizao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2998-458X","authenticated-orcid":false,"given":"Huihong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"issue":"3","key":"3860_CR1","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.ymgme.2018.11.012","volume":"128","author":"M Yasuda","year":"2019","unstructured":"Yasuda M, Chen B, Desnick RJ. Recent advances on porphyria genetics: inheritance, penetrance & molecular heterogeneity, including new modifying\/causative genes. Mol Genet Metab. 2019;128(3):320\u201331.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"3860_CR2","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ymgme.2019.04.008","volume":"128","author":"JD Phillips","year":"2019","unstructured":"Phillips JD. Heme biosynthesis and the porphyrias. Mol Genet Metab. 2019;128(3):164\u201377.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"3860_CR3","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s13023-024-03287-7","volume":"19","author":"Y Wang","year":"2024","unstructured":"Wang Y, Li N, Zhang S. Estimating carrier rates and prevalence of porphyria-associated gene variants in the Chinese population based on genetic databases. Orphanet J Rare Dis. 2024;19(1):337.","journal-title":"Orphanet J Rare Dis"},{"key":"3860_CR4","doi-asserted-by":"publisher","first-page":"101928","DOI":"10.1016\/j.pdpdt.2020.101928","volume":"32","author":"IM Heerfordt","year":"2020","unstructured":"Heerfordt IM, Lerche CM, Wulf HC. Trends in erythrocyte protoporphyrin IX concentration by age, sex and season among patients with erythropoietic protoporphyria-20 years of follow-up. Photodiagn Photodyn Ther. 2020;32:101928.","journal-title":"Photodiagn Photodyn Ther"},{"key":"3860_CR5","doi-asserted-by":"crossref","unstructured":"Puy H, Gouya L, Deybach JC, Porphyrias. Lancet (London England). 2010;375(9718):924\u201337.","DOI":"10.1016\/S0140-6736(09)61925-5"},{"key":"3860_CR6","doi-asserted-by":"publisher","first-page":"101582","DOI":"10.1016\/j.pdpdt.2019.101582","volume":"29","author":"HC Wulf","year":"2020","unstructured":"Wulf HC, Nissen CV, Philipsen PA. Inactivation of protoporphyrin IX in erythrocytes in patients with erythropoietic protoporphyria: A new treatment modality. Photodiagn Photodyn Ther. 2020;29:101582.","journal-title":"Photodiagn Photodyn Ther"},{"issue":"12","key":"3860_CR7","doi-asserted-by":"publisher","first-page":"4108","DOI":"10.1182\/blood-2007-04-088120","volume":"110","author":"SA Holme","year":"2007","unstructured":"Holme SA, Worwood M, Anstey AV, Elder GH, Badminton MN. Erythropoiesis and iron metabolism in dominant erythropoietic protoporphyria. Blood. 2007;110(12):4108\u201310.","journal-title":"Blood"},{"issue":"7","key":"3860_CR8","first-page":"1332","volume":"33","author":"L XiaoQing","year":"2017","unstructured":"XiaoQing L, Jie S, YaMin L, BoWei Z, LiNa W, LiMing Z, et al. - Erythropoietic protoporphyria with jaundice as the main manifestation:a clinical, pathological, and genetic analysis of 4 cases. J Clin Hepatol. 2017;33(7):1332\u20135.","journal-title":"J Clin Hepatol"},{"issue":"1","key":"3860_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1086\/498620","volume":"78","author":"L Gouya","year":"2006","unstructured":"Gouya L, Martin-Schmitt C, Robreau AM, Austerlitz F, Da Silva V, Brun P, et al. Contribution of a common single-nucleotide polymorphism to the genetic predisposition for erythropoietic protoporphyria. Am J Hum Genet. 2006;78(1):2\u201314.","journal-title":"Am J Hum Genet"},{"key":"3860_CR10","doi-asserted-by":"crossref","unstructured":"Gouya L, Puy H, Robreau AM, Bourgeois M, Lamoril J, Da Silva V, et al. The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH. Nat Genet. 2002;30(1):27\u20138.","DOI":"10.1038\/ng809"},{"issue":"7","key":"3860_CR11","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3748\/wjg.v25.i7.880","volume":"25","author":"HM Liu","year":"2019","unstructured":"Liu HM, Deng GH, Mao Q, Wang XH. Diagnosis of erythropoietic protoporphyria with severe liver injury: A case report. World J Gastroenterol. 2019;25(7):880\u20137.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"3860_CR12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Medicine: Official J Am Coll Med Genet. 2015;17(5):405\u201324.","journal-title":"Genet Medicine: Official J Am Coll Med Genet"},{"issue":"1","key":"3860_CR13","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1038\/s41467-022-31686-6","volume":"13","author":"L Gerasimavicius","year":"2022","unstructured":"Gerasimavicius L, Livesey BJ, Marsh JA. Loss-of-function, gain-of-function and dominant-negative mutations have profoundly different effects on protein structure. Nat Commun. 2022;13(1):3895.","journal-title":"Nat Commun"},{"issue":"5","key":"3860_CR14","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1172\/JCI108189","volume":"56","author":"HL Bonkowsky","year":"1975","unstructured":"Bonkowsky HL, Bloomer JR, Ebert PS, Mahoney MJ. Heme synthetase deficiency in human protoporphyria. Demonstration of the defect in liver and cultured skin fibroblasts. J Clin Investig. 1975;56(5):1139\u201348.","journal-title":"J Clin Investig"},{"issue":"2","key":"3860_CR15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1172\/JCI109675","volume":"65","author":"JR Bloomer","year":"1980","unstructured":"Bloomer JR. Characterization of deficient Heme synthase activity in protoporphyria with cultured skin fibroblasts. J Clin Investig. 1980;65(2):321\u20138.","journal-title":"J Clin Investig"},{"issue":"8","key":"3860_CR16","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1001\/jamadermatol.2017.1557","volume":"153","author":"M Balwani","year":"2017","unstructured":"Balwani M, Naik H, Anderson KE, Bissell DM, Bloomer J, Bonkovsky HL, et al. Clinical, biochemical, and genetic characterization of North American patients with erythropoietic protoporphyria and X-linked protoporphyria. JAMA Dermatology. 2017;153(8):789\u201396.","journal-title":"JAMA Dermatology"},{"key":"3860_CR17","doi-asserted-by":"crossref","unstructured":"Balwani M, Doheny D, Bishop DF, Nazarenko I, Yasuda M, Dailey HA et al. Loss-of-function ferrochelatase and gain-of-function erythroid-specific 5-aminolevulinate synthase mutations causing erythropoietic protoporphyria and x-linked protoporphyria in North American patients reveal novel mutations and a high prevalence of X-linked protoporphyria. Molecular medicine (Cambridge, Mass). 2013;19(1):26\u201335.","DOI":"10.2119\/molmed.2012.00340"},{"issue":"2","key":"3860_CR18","first-page":"292","volume":"58","author":"L Gouya","year":"1996","unstructured":"Gouya L, Deybach JC, Lamoril J, Da Silva V, Beaumont C, Grandchamp B, et al. Modulation of the phenotype in dominant erythropoietic protoporphyria by a low expression of the normal ferrochelatase allele. Am J Hum Genet. 1996;58(2):292\u20139.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"3860_CR19","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1182\/blood-2014-07-584664","volume":"126","author":"DN Egan","year":"2015","unstructured":"Egan DN, Yang Z, Phillips J, Abkowitz JL. Inducing iron deficiency improves erythropoiesis and photosensitivity in congenital erythropoietic porphyria. Blood. 2015;126(2):257\u201361.","journal-title":"Blood"},{"issue":"1","key":"3860_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.bcmd.2014.07.017","volume":"54","author":"J Barman-Aks\u00f6zen","year":"2015","unstructured":"Barman-Aks\u00f6zen J, Minder EI, Schubiger C, Biolcati G, Schneider-Yin X. In ferrochelatase-deficient protoporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin concentration correlates with iron availability. Blood Cells Mol Dis. 2015;54(1):71\u20137.","journal-title":"Blood Cells Mol Dis"},{"issue":"1","key":"3860_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/jdv.20269","volume":"39","author":"M B\u00f6hm","year":"2025","unstructured":"B\u00f6hm M, Robert C, Malhotra S, Cl\u00e9ment K, Farooqi S. An overview of benefits and risks of chronic melanocortin-1 receptor activation. J Eur Acad Dermatol Venereol. 2025;39(1):39\u201351.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"15","key":"3860_CR22","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1056\/NEJMoa2208754","volume":"388","author":"M Balwani","year":"2023","unstructured":"Balwani M, Bonkovsky HL, Levy C, Anderson KE, Bissell DM, Parker C, et al. Dersimelagon in erythropoietic protoporphyrias. N Engl J Med. 2023;388(15):1376\u201385.","journal-title":"N Engl J Med"},{"issue":"8","key":"3860_CR23","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.chembiol.2021.02.021","volume":"28","author":"F Halloy","year":"2021","unstructured":"Halloy F, Iyer PS, Ghidini A, Lysenko V, Barman-Aks\u00f6zen J, Grubenmann CP, et al. Repurposing of glycine transport inhibitors for the treatment of erythropoietic protoporphyria. Cell Chem Biology. 2021;28(8):1221\u2013e346.","journal-title":"Cell Chem Biology"},{"key":"3860_CR24","doi-asserted-by":"publisher","first-page":"102793","DOI":"10.1016\/j.pdpdt.2022.102793","volume":"38","author":"IM Heerfordt","year":"2022","unstructured":"Heerfordt IM, Lerche CM, Wulf HC. Cimetidine for erythropoietic protoporphyria. Photodiagn Photodyn Ther. 2022;38:102793.","journal-title":"Photodiagn Photodyn Ther"},{"issue":"6","key":"3860_CR25","doi-asserted-by":"publisher","first-page":"101463","DOI":"10.1016\/j.jcmgh.2025.101463","volume":"19","author":"N Kuo","year":"2025","unstructured":"Kuo N, Li P, Cunha JB, Chen L, Shavit JA, Omary MB. The Histamine pathway is a target to treat hepatic experimental erythropoietic protoporphyria. Cell Mol Gastroenterol Hepatol. 2025;19(6):101463.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"1","key":"3860_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1053\/j.gastro.2023.07.028","volume":"166","author":"Q Zeng","year":"2024","unstructured":"Zeng Q, Wu D, Tang H. A mysterious abdominal pain. Gastroenterology. 2024;166(1):27\u201330.","journal-title":"Gastroenterology"},{"issue":"3","key":"3860_CR27","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/ajt.14581","volume":"18","author":"AL Windon","year":"2018","unstructured":"Windon AL, Tondon R, Singh N, Abu-Gazala S, Porter DL, Russell JE, et al. Erythropoietic protoporphyria in an adult with sequential liver and hematopoietic stem cell transplantation: A case report. Am J Transplantation: Official J Am Soc Transplantation Am Soc Transpl Surg. 2018;18(3):745\u20139.","journal-title":"Am J Transplantation: Official J Am Soc Transplantation Am Soc Transpl Surg"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03860-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03860-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03860-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:44:48Z","timestamp":1781613888000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-025-03860-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3860"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03860-8","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"27 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted with approval from the Ethics Committee of the Second Affiliated Hospital of Chongqing Medical University. Informed consent was obtained from all participants involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from the participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"333"}}